GAMBARAN KEPATUHAN BEROBAT PASIEN RETINOPATI DIABETIK DI PMN RS MATA CICENDO 2021–2022
DOI:
https://doi.org/10.11594/ojkmi.v5i2.54Keywords:
kepatuhan berobat, retinopati diabetikAbstract
Pendahuluan: Retinopati diabetik (RD) merupakan komplikasi mikrovaskular penyakit diabetes melitus dengan angka pertumbuhan tinggi. Kepatuhan melakukan pemeriksaan rutin dan menjalankan tindakan khusus dapat mencegah progresivitas penyakit ini. Namun, penelitian mengenai gambaran kepatuhan berobat pasien retinopati diabetik belum pernah dilakukan di Indonesia. Penelitian ini bertujuan untuk mengetahui gambaran kepatuhan berobat pasien retinopati diabetik di PMN RS Mata Cicendo.
Metode: Penelitian ini merupakan penelitian observasional deskriptif dengan metode cross sectional, menggunakan data sekunder dari EMR, dan dilakukan pada periode 1 Januari 2021–31 Desember 2022 di PMN RS Mata Cicendo. Kepatuhan dinilai berdasarkan kepatuhan menjalankan masa awal pengobatan dan diukur melalui data tanggal registrasi, tindakan, dan perencanaan. Hasil penilaian kepatuhan kemudian dikelompokkan berdasarkan derajat retinopati diabetik, tipe diabetes melitus, jenis tindakan, jenis kelamin, usia, pekerjaan, pendidikan terakhir, dan domisili.
Hasil: Penelitian ini melibatkan 887 rekam medis dan 533 (60,1%) di antaranya dikategorikan patuh. Data menunjukkan persentase kepatuhan >60% pada pasien derajat berat seperti Proliverative Diabetic Retinopathy (61,6%); berjenis kelamin perempuan (60,2%); berusia muda kelompok 25–34 tahun (77,4%); berdomisili di Bandung Raya (64,4%) atau luar Jawa Barat (63,5%); berpendidikan terakhir tinggi sarjana muda (68,9%); bekerja sebagai pegawai swasta (67,1%), pengajar (72,7%), wiraswasta (61,3%), atau pensiunan (66,7%); memiliki tipe diabetes melitus terspesifikasi non-insulin dependent (64,2%) atau insulin dependent (80,9%); serta mendapat rekomendasi tindakan laser (64,1%).
Kesimpulan: Secara umum kepatuhan berobat pasien retinopati diabetik di PMN RS Mata Cicendo sudah mencapai >60%. Kepatuhan pasien kontrol dengan jangka waktu menengah (1–3 bulan), panjang (>6 bulan) masih harus ditingkatkan.
Downloads
References
International Diabetes Federation. IDF Diabetes Atlas 10th edition [Internet]. Brussels, Belgium; 2021 [cited 2023 Feb 26]. Available from: https://www.diabetesatlas.org
Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes [Internet]. 2008 Apr 1;26(2):77–82. Available from: http://clinical.diabetesjournals.org
Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021 Nov 1;128(11):1580–91.
Available from: https://pubmed.ncbi.nlm.nih.gov/33940045/
Sasongko MB, Widyaputri F, Agni AN, Wardhana FS, Kotha S, Gupta P, et al. Prevalence of Diabetic Retinopathy and Blindness in Indonesian Adults With Type 2 Diabetes. Am J Ophthalmol. 2017 Sep 1;181:79–87. Available from: https://pubmed.ncbi.nlm.nih.gov/28669781/
Maulana DCE, Sowani I. Pola Rujukan Pasien Retinopati Diabetik Di Pusat Rujukan Tersier Pusat Mata Nasional Rumah Sakit Mata Cicendo Indonesia Tahun 2-16-2019 [Internet]. 2016 [cited 2023 Mar 14]. Available from: https://perpustakaanrsmcicendo.com/2020/10/05/pola-rujukan-pasien-retinopati-diabetik-di-pusat-rujukan-tersier-pusat-mata-nasional-rumah-sakit-mata-cicendo-indonesia-tahun-2016-2019/
Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol [Internet]. 2015 Dec;44(4):260–77. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ceo.12696
Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. Diabetic Retinopathy Preferred Practice Pattern. Ophthalmology. 2020 Jan 1;127(1):P66–145. Available from:
https://pubmed.ncbi.nlm.nih.gov/31757498/
Murchison AP, Hark L, Pizzi LT, Dai Y, Mayro EL, Storey PP, et al. Non-adherence to eye care in people with diabetes. BMJ Open Diabetes Res Care. 2017 Jul 1;5(1). Available from :
https://pubmed.ncbi.nlm.nih.gov/28878930/
Kao CC, Hsieh HM, Lee DY, Hsieh KP, Sheu SJ. Importance of medication adherence in treatment needed diabetic retinopathy. Sci Rep. 2021 Dec 1;11(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34580364/
Ahmed I, Liu TYA. The Impact of COVID-19 on Diabetic Retinopathy Monitoring and Treatment. Curr Diab Rep. 2021 Oct 1;21(10). Available from:
https://pubmed.ncbi.nlm.nih.gov/34495377/
Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes [Internet]. 2015;6(1):92. Available from: http://www.wjgnet.com/1948-9358/full/v6/i1/92.htm
International Federation on Ageing (IFA), International Diabetes Federation (IDF), International Agency for the Prevention of Blindness (IAPB). The Diabetic Retinopathy Barometer Report Global Findings [Internet]. 2020 [cited 2023 Feb 28]. Available from: https://idf.org/our-activities/care-prevention/eye-health/dr-barometer.html
Persatuan Dokter Spesialis Mata Indonesia (Perdami). Pedoman Nasional Pelayanan Kedokteran RETINOPATI DIABETIKA. Dameria D, Andayani G, Rahman K, Soedarman S, editors. 2018. Available from: https://perdami.or.id/wp-content/uploads/2022/03/Panduan-Nasional-Pelayanan-Kedokteran-Retinopati-Diabetik.pdf
US Department of Health and Human Services C for DC and P. Age-Adjusted Percentage of Adults Aged ≥18 Years Reporting Diabetic Retinopathy Among Those with Prediabetes or Diagnosed Diabetes, by Age Group—National Health Interview Survey,2016–2017 [Internet]. 2019 May [cited 2023 Aug 1]. Available from: https://www.cdc.gov/mmwr/volumes/68/wr/mm6821a5.htm
Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: Terminology and definitions. Value in Health. 2008;11(1):44–7. Available from:
https://pubmed.ncbi.nlm.nih.gov/18237359/
Shahzad H, Mahmood S, McGee S, Hubbard J, Haque S, Paudyal V, et al. Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis. Syst Rev. 2023 Jun 2;12(92). Available from:
https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-023-02261-x
Abdelmotaal H, Ibrahim W, Sharaf M, Abdelazeem K. Causes and Clinical Impact of Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy. J Ophthalmol. 2020 Feb 8; Available from: https://pubmed.ncbi.nlm.nih.gov/32089871/
Al Taisan A, Al Owaifeer AM, Al Osaif N, Al Saeed AA, Al Furaikh BF, Al Jamaan LF. Assessment of Diabetic Patients’ Adherence to Diabetic Retinopathy Screening and the Influencing Factors in Al-Ahsa, Saudi Arabia. Cureus. 2022 Aug 22;14(8). Available from: https://pubmed.ncbi.nlm.nih.gov/36158328/
Kelkar A, Webers C, Shetty R, Kelkar J, Labhsetwar N, Pandit A, et al. Factors affecting compliance to intravitreal antivascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, agerelated macular degeneration, and diabetic macular edema. Indian J Ophthalmol . 2020 Sep 23;68:2143–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32971626/
Tian J, Wisely C, Shaffer L, Padmanabhan A, Al Gora. Factors that affect adherence to diabetic retinopathy screening guidelines in an underserved ED population. Invest Ophthalmol Vis Sci. 2020 Jun;61. Available from: https://iovs.arvojournals.org/article.aspx?articleid=2769833
Cleland CR, Matsinhe C, Makupa WU, Philippin H. Gender bias within a diabetic retinopathy screening programme in Tanzania. Eye. 2022 May 19;36:33–9. Available from: https://pubmed.ncbi.nlm.nih.gov/35590053/
Keenum Z, McGwin G, Witherspoon D, Haller JA, Clark ME, Owsley C. Patients’ Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors AssociatedWith Follow-up Eye Care Use. JAMA Ophthalmol. 2016 Sep 15;134(11):1221–8. Available from: https://pubmed.ncbi.nlm.nih.gov/27632231/
Angermann R, Rauchegger T, Nowosielski Y, Casazza M, Bilgeri A, Ulmer H, et al. Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2019 Jul 9;257:2119–25. Available from: https://pubmed.ncbi.nlm.nih.gov/31286206/
Leese GP, Boyle P, Feng Z, Smith AE, Ellis JD. Screening Uptake in a Well-Established Diabetic Retinopathy Screening Program : The role of geographical access and deprivation. Diabetes Care. 2008 Aug 15;31(11):2131–5. Available from:
https://pubmed.ncbi.nlm.nih.gov/18728235/
Hua W, Cae S, Cui J, Maberley D, Matsubara J. Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy. Can J Ophthalmol. 2017 Nov;52. Available from:
https://pubmed.ncbi.nlm.nih.gov/29074011/
Al Hargan MH, Al Baker KM, Al Fadehl AA, Al Ghamdi MA, Al Muammar SM, Al Dawood HA. Awareness, knowledge, and practices related to diabetic retinopathy among diabetic patients in primary healthcare centers at Riyadh, Saudi Arabia. J Family Med Prim Care. 2019 Feb;373–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436279/
Thapa R, Poudyal G, Maharjan N, Bernstein PS. Demographics and awareness of diabetic retinopathy among diabetic patients attending the vitreo-retinal service at a tertiary eye care center in Nepal. Nepal J Ophthalmol. 2012 Jun;4(1). Available from: https://pubmed.ncbi.nlm.nih.gov/22343990/
Alwazae M, Al Adel F, Ahumud A, Almutairi A, Alhumidan A, Elmorshedy H. Barriers for Adherence to Diabetic Retinopathy Screening among Saudi Adults. Cureus. 2019 Dec 23;11(12). Available from: https://pubmed.ncbi.nlm.nih.gov/31897356/
Bresnick G, Cuadros JA, Khan M, Fleischmann S, Wolff G, Limon A, et al. Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting. BMJ Open Diabetes Res Care. 2020 Jun 23;8(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32576560/
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Oftalmologi: Jurnal Kesehatan Mata Indonesia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a 